Ketao Jin

14PUBLICATIONS
20CO-AUTHORS
Molecular targetsNanomaterialsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NanomedicineTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 29, 2026
Nanozyme-Assisted Engineered Oncolytic Adenovirus for Improving Intratumoral Immune Deficiency and Enhancing Cancer Immunotherapy.

|Apr 06, 2026
Natural Polymers Based Biocompatible Nanomedicines for Targeting Colon Cancer: Prospects and Challenges.

Qi Wang, Zhendong Liu, Ketao Jin

|Jan 01, 2026
Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Nanovesicles Alleviated Colitis via Modulating Th17/Treg Balance Through Hsa-miR-27b-3p-Mediated Suppression of PI3K/AKT/STAT3 Signaling Pathway.

Yuanhao Zhou, Yuanyuan Wang, Yilin Huang

|Jun 11, 2025
Theranostic Role of Advanced Nanotechnological Tools in Early Brain Metastases in Lung Cancer: An Updated Review.

Yuanlin Wu, Caiping Sun, Ketao Jin

|May 01, 2025
Reproducible extracellular matrices for tumor organoid culture: challenges and opportunities.

Kan Li, Yibo He, Xue Jin

|Aug 02, 2024
An Engineered Self-biomineralized Oncolytic Adenovirus Induces Effective Antitumor Immunity and Synergizes With Immune Checkpoint Blockade.

Shibing Wang, Xue Yang, Ying-Yu Ma

Pageof 3

Frequent Collaborators

4 joint publications

Xiaozhou Mou

1 joint publications

Li-Feng Hu

1 joint publications

Huan-Rong Lan

1 joint publications

Xue-Min Li